Press Releases

Date	Title	Company
02-May-2022	Original-Research: MPH Health Care AG (von First Berlin Equity Research GmbH)	MPH Health Care AG
02-May-2022	Rise In Incidences Of Cardiovascular Disease Throughout The Globe Is The Primary Factor Driving The Growth Of Iliac Artery Stents Market: Fact.MR	MARKITWIRED Latest Market Reports
02-May-2022	Demand For Cryoprecipitated Antihemophilic Factor Market Is Set To Grow At A Higher Pace Over The Medium- And Long-Run During 2022-2032: Fact.MR	MARKITWIRED Latest Market Reports
02-May-2022	Metal Coronary Stent Grafts Are Expected To Be A Dominant Segment In The Global Coronary Stent Grafts Market During 2022-2032	MARKITWIRED Latest Market Reports
02-May-2022	Artificial Eyes Market Is Expected To See Remarkable Growth In The Forecast Period Due To Increasing Number Demand By A Large Number Of Patient Population: Fact.MR	MARKITWIRED Latest Market Reports
02-May-2022	Asia-Pacific Market For Carbapenem-Resistant Enterobacteriaceae Testing Is Expected To Expand During 2022-2032	MARKITWIRED Latest Market Reports
02-May-2022	High-Sensitivity Cardiac Biomarker Market Is Expected To Be A Growing Market Over The Forecast Period 2022-2032	MARKITWIRED Latest Market Reports
02-May-2022	OSE Immunotherapeutics Announces New European Patent Granted Covering CLEC-1, Novel Myeloid Immune Checkpoint Target For Cancer Immunotherapy	Businesswire
02-May-2022	Europe Is Expected To Witness Significant Growth In The Global Market As The Adoption Of Nerve Ablation Devices Among Patient And Healthcare Professionals Has Increased	MARKITWIRED Latest Market Reports
02-May-2022	Asia Pacific Is Expected To Register Growth During The Forecast Period As Several Companies Are Working On Supplying Customised Veterinary Tables: Fact.MR Report	MARKITWIRED Latest Market Reports
02-May-2022	North America Pressure Infusion Cuffs Market Is Expected To Generate Sluggish Growth Owing To Saturation With The U.S. Leading The Market: Fact.MR Report	MARKITWIRED Latest Market Reports
02-May-2022	NEXEL Earns the First ISO/IEC 17025:2017 Accreditation for iPSC-derived Cardiomyocyte-based Cardiac Safety Testing	Businesswire
02-May-2022	Europäische Kommission erteilt UPLIZNA® (Inebilizumab) die Zulassung zur Behandlung von Erwachsenen mit Neuromyelitis-optica-Spektrum-Erkrankungen (NMOSD)	Businesswire
02-May-2022	Horizon Therapeutics plc reçoit l’approbation de la Commission européenne (CE) pour UPLIZNA® (inébilizumab) dans le traitement des adultes atteints de troubles du spectre de la neuromyélite optique (NMOSD)	Businesswire
02-May-2022	Horizon Therapeutics riceve l’approvazione della Commissione europea (CE) per inebilizumab per il trattamento di adulti affetti da disturbo dello spettro della neuromielite ottica (NMOSD)	Businesswire
02-May-2022	Horizon Therapeutics plc Receives European Commission (EC) Approval of UPLIZNA® (inebilizumab) for the Treatment of Adults With Neuromyelitis Optica Spectrum Disorder (NMOSD)	Businesswire
02-May-2022	Biotest AG: Biotest Supervisory Board appoints new Management Board member	Biotest AG
02-May-2022	Demand For Atherosclerosis Drugs Market To Witness An Outstanding Growth By 2027 \| Fact.MR Study	MARKITWIRED Latest Market Reports
02-May-2022	Cardiac Ablation Technologies Market Is Representing A Y-O-Y Increase Of 11.1% During 2022-2032 \| Fact.MR study	MARKITWIRED Latest Market Reports
02-May-2022	Demand For Asthma Treatment Market To Witness An Outstanding Growth By 2027 \| Fact.MR Study	MARKITWIRED Latest Market Reports